44 results
Page 2 of 3
6-K
EX-99.1
0gdge2e0aqw3vzaz6tf
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
7t8 kkgr5jhc848
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.1
o6fhvk4k3bmv2
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
cpo l2xbhvujcw
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
7qzofts36
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
op6jh16fg5
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
4v0km bur
18 Dec 20
Draft registration statement
12:00am
6-K
EX-10.1
9uxbp3
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
3b9gwt4g
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
424B4
9teczbn
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
ysh0oayak4xr wm
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-2.2
lx9b0dwvp
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.5
weduxy3m qfn
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.7
49lbjfnbhmd1rhj
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.1
7qw4tc
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.3
83az4yf2wv4lhxn6
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.2
iuwtxp ej
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
ls7ti8r1 cabx01iwvd
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
ajfkv8pyq2qtl7o0zzdg
29 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.2
aq9f61a24 qj
11 May 20
Draft registration statement (amended)
12:00am